Jian; Tianying

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jian; Tianying.The latest application filed is for "factor xi activation inhibitors".

Company Profile

7.13.19

Jian; Tianying - Westfield NJ
JIAN; Tianying - Rahway NJ US
Jian, Tianying - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Factor Xi Activation Inhibitors App 20220235033 - Hicks; Jacqueline D. ; et al.	2022-07-28
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,968,210 - Greshock , et al. April 6, 2	2021-04-06
Diamino-alkylamino-linked Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20200131167 - Greshock; Thomas J. ; et al.	2020-04-30
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,519,147 - Greshock , et al. Dec	2019-12-31
Factor IXa inhibitors Grant 10,351,558 - Meng , et al. July 16, 2	2019-07-16
Factor IXa inhibitors Grant 10,189,819 - Zhang , et al. Ja	2019-01-29
DIAMINO-ALKYLAMINO-Linked ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS App 20180362518 - Greshock; Thomas J. ; et al.	2018-12-20
Factor IXa Inhibitors App 20180030036 - Zhang; Ting ; et al.	2018-02-01
Factor IXa Inhibitors App 20180022747 - Meng; Dongfang ; et al.	2018-01-25
Imidazole Derivatives App 20140088124 - DeVita; Robert J. ; et al.	2014-03-27
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators Grant 8,293,900 - Jian , et al. October 23, 2	2012-10-23
Substituted imidazoles as bombesin receptor subtype-3 modulators Grant 8,183,275 - Dobbelaar , et al. May 22, 2	2012-05-22
Substituted imidazoles as bombesin receptor subtype-3 modulators App 20100204236 - Dobbelaar; Peter H. ; et al.	2010-08-12
Beta Carboline Derivatives As Antidiabetic Compounds App 20100184758 - Dobbelaar; Peter H. ; et al.	2010-07-22
Acylated piperidine derivatives as melanocortin-4 receptor modulators App 20090253744 - Bakshi; Raman K. ; et al.	2009-10-08
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators App 20090170863 - Jian; Tianying ; et al.	2009-07-02
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists Grant 7,329,673 - Guo , et al. February 12, 2	2008-02-12
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists App 20060183904 - Guo; Liangqin ; et al.	2006-08-17
23-O-substituted 5-O-mycaminosyltylonide derivatives App 20050020823 - Phan, Ly Tam ; et al.	2005-01-27
23-O-substituted 5-O-mycaminosyltylonide derivatives Grant 6,753,415 - Phan , et al. June 22, 2	2004-06-22
4'-substituted leucomycins Grant 6,680,299 - Or , et al. January 20, 2	2004-01-20
23-O-substituted 5-O-mycaminosyltylonide derivatives App 20030212010 - Phan, Ly Tam ; et al.	2003-11-13
4'-O-substituted tylosin analogs Grant 6,576,615 - Phan , et al. June 10, 2	2003-06-10
4' -substituted Leucomycins App 20030096763 - Or, Yat Sun ; et al.	2003-05-22
4'-o-substituted Tylosin Analogs App 20030092639 - Phan, Ly Tam ; et al.	2003-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.